Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-26

Clinical Trial Update: Safety of the Herpes Zoster Subunit Vaccine in Lupus [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the safety of a herpes zoster subunit vaccine in patients with Systemic Lupus Erythematosus and is currently recruiting a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Herpes Zoster Subunit Vaccine

Snippet

Sponsor: NYU Langone Health | Conditions: Systemic Lupus Erythematosus | Phase 4 | Status: RECRUITING